Company: INMB
Filing Date: 2025-10-14
Form Type: DEF 14A
Source: 0001213900-25-098715
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-10-14
Form: DEF 14A
Chunk 1
---
 Incentive Plan (as may be amended, restated or otherwise modified from time to time in accordance with its terms, the “2021 Plan”) (the “Option Repricing Proposal” or “Proposal 1”); 2.To approve a proposal to adjourn the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of additional proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Repricing Proposal at the time of the Special Meeting (the “Adjournment Proposal” or “Proposal 2”); and 3.To transact such other business as may properly come before the Special Meeting or any continuations, adjournments, and postponements thereof. The foregoing items of business are more fully described in the proxy statement accompanying this Notice of Special Meeting. Our Board of Directors has established the close of business on September 30, 2025, as the “record date” for the Special Meeting. This means that you are entitled to notice of, and to vote at, the Special Meeting or any continuations, adjournments, and postponements thereof if our stock records show that you owned our common stock at that time. In accordance with the rules of the Securities and Exchange Commission (the “SEC”), we have elected to provide our proxy materials to our stockholders using the “full set delivery option” in connection with the Special Meeting, pursuant to Rule 14a -16(n) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result, we are delivering to our stockholders paper copies of the accompanying proxy statement and form of proxy card (collectively, the “Proxy Materials”) by mail. In addition to delivery of the Proxy Materials to our stockholders, we will post the Proxy Materials on a publicly accessible website and provide information to our stockholders about how to access the website. The proxy statement is dated October14, 2025 and is first being mailed to stockholders on or about October14, 2025. Please see the “Information About the Special Meeting and Voting” section of the proxy statement that accompanies this notice for more details regarding the logistics of the virtual Special Meeting, including the ability of stockholders to submit questions during the Special Meeting, and technical details and support related to accessing the virtual platform. There is no physical location for the Special Meeting. You will not be able to attend the Special Meeting in person.

Your vote is important.Whether